Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2002;39:394-398
doi: 10.1161/hy02t2.102793
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Banes, A. K.L.
Right arrow Articles by Watts, S. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Banes, A. K.L.
Right arrow Articles by Watts, S. W.
Related Collections
Right arrow Animal models of human disease
Right arrow Gene expression
Right arrow Gene regulation
Right arrow Hypertension - basic studies

(Hypertension. 2002;39:394.)
© 2002 American Heart Association, Inc.


Scientific Contributions

Upregulation of Arterial Serotonin 1B and 2B Receptors in Deoxycorticosterone Acetate-Salt Hypertension

Amy K.L. Banes; Stephanie W. Watts

From the Department of Pharmacology and Toxicology, Michigan State University, East Lansing.

Reprint requests to Dr Amy Banes, Department of Pharmacology and Toxicology, Michigan State University, B445 Life Sciences Bldg, East Lansing, MI 48824. E-mail banesamy{at}msu.edu

Previous studies have established a role for 5-hydroxytryptamine (5-HT)2B and 5-HT1B receptors in mediating enhanced contraction to serotonin (5-HT) in arteries from hypertensive deoxycorticosterone acetate (DOCA)-salt rats. To determine whether the observed increase in responsiveness was due to upregulation of 5-HT receptors, we used Western analysis to measure 5-HT1B and 5-HT2B receptor protein density. In endothelium-denuded aortas from hypertensive DOCA-salt rats (mean systolic blood pressure 192±6 mm Hg), 5-HT1B and 5-HT2B receptor proteins were upregulated {approx}2-fold compared with the response in the aortas of sham-operated control rats (mean systolic blood pressure 119±2 mm Hg). Contraction to 5-HT2B receptor agonists was also enhanced in arteries from Wistar-Furth rats given DOCA and salt. This strain is relatively resistant to the hypertensive effects of DOCA and salt treatment. A common factor between the model of DOCA-salt hypertension and the DOCA-salt–treated Wistar-Furth rats is the presence of mineralocorticoids. Therefore, we tested the hypothesis that mineralocorticoids can upregulate 5-HT1B and 5-HT2B receptors. Aortas from normal Sprague-Dawley rats were incubated with aldosterone (100 nmol/L) for 8, 12, 24, and 48 hours. The expression of 5-HT2B and 5-HT1B receptor proteins was significantly increased ({approx}2- fold over vehicle treatment) by 8 hours. 5-HT2B and 5-HT1B receptors were upregulated by aldosterone in a concentration-dependent manner, and incubation with spironolactone (10 µmol/L) blocked this upregulation. These data support the conclusion that the increased expression of 5-HT1B and 5-HT2B receptors observed in arteries from DOCA-salt rats may be partially due to mineralocorticoids acting via the mineralocorticoid receptor to modulate gene expression.


Key Words: serotonin • aldosterone • arteries • hypertension, sodium-dependent • receptors, serotonin




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. W. Watts
The love of a lifetime: 5-HT in the cardiovascular system
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2009; 296(2): R252 - R256.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
W. Ni, G. D. Fink, and S. W. Watts
The 5-Hydroxytryptamine2A Receptor Is Involved in (+)-Norfenfluramine-Induced Arterial Contraction and Blood Pressure Increase in Deoxycorticosterone Acetate-Salt Hypertension
J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 485 - 491.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Erdely, G. Freshour, Y.-L. Tain, K. Engels, and C. Baylis
DOCA/NaCl-induced chronic kidney disease: a comparison of renal nitric oxide production in resistant and susceptible rat strains
Am J Physiol Renal Physiol, January 1, 2007; 292(1): F192 - F196.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Ogden, J. M. Thompson, Z. Hickner, T. Huang, D. D. Tang, and S. W. Watts
A new signaling paradigm for serotonin: use of Crk-associated substrate in arterial contraction
Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2857 - H2863.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y.-J. Liang, L.-P. Lai, B.-W. Wang, S.-J. Juang, C.-M. Chang, J.-G. Leu, and K.-G. Shyu
Mechanical stress enhances serotonin 2B receptor modulating brain natriuretic peptide through nuclear factor-{kappa}B in cardiomyocytes
Cardiovasc Res, November 1, 2006; 72(2): 303 - 312.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. K. L. Banes, S. M. Shaw, A. Tawfik, B. P. Patel, S. Ogbi, D. Fulton, and M. B. Marrero
Activation of the JAK/STAT pathway in vascular smooth muscle by serotonin
Am J Physiol Cell Physiol, April 1, 2005; 288(4): C805 - C812.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. W. Watts and J. M. Thompson
Characterization of the Contractile 5-Hydroxytryptamine Receptor in the Renal Artery of the Normotensive Rat
J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 165 - 172.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Russell, A. Banes, H. Berlin, G. D. Fink, and S. W. Watts
5-Hydroxytryptamine2B Receptor Function Is Enhanced in the Nomega -Nitro-L-arginine Hypertensive Rat
J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 179 - 187.
[Abstract] [Full Text] [PDF]